Rosetta Genomics Ltd. (NASDAQ:ROSG) will issue its quarterly earnings data after the market closes on Wednesday, August 16th.

Shares of Rosetta Genomics Ltd. (NASDAQ:ROSG) opened at 1.73 on Wednesday. Rosetta Genomics Ltd. has a 12-month low of $1.40 and a 12-month high of $13.32. The stock has a 50 day moving average of $2.14 and a 200 day moving average of $3.36. The company’s market cap is $3.23 million.

WARNING: This report was reported by Daily Political and is the property of of Daily Political. If you are accessing this report on another publication, it was illegally copied and republished in violation of international trademark & copyright laws. The original version of this report can be viewed at

About Rosetta Genomics

Rosetta Genomics Ltd. is engaged in developing and commercializing new diagnostic tests based on various genomics markers, including deoxyribonucleic acid (DNA), micro ribonucleic acid (microRNA) and protein biomarkers and using various technologies, including, Quantitative polymerase chain reaction (qPCR), microarrays, Next Generation Sequencing (NGS) and Fluorescence In Situ Hybridization (FISH).

Receive News & Ratings for Rosetta Genomics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rosetta Genomics Ltd. and related companies with's FREE daily email newsletter.